Baker Avenue Asset Management, LP - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 195 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Avenue Asset Management, LP ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$697
-5.0%
29
+26.1%
0.00%
Q2 2023$734
+87.7%
23
+130.0%
0.00%
Q4 2022$391100.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders